20 (AIDX) Free Cash Flow (2025 - 2026)
20's (AIDX) quarterly Free Cash Flow came in at -$1.3 million in Q1 2026, down 163.97% YoY from $2.0 million in Q1 2025, and down 163.97% on a QoQ basis from -$488293.0 in Q1 2025.
20 (AIDX) Free Cash Flow (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Free Cash Flow data on file, last reported at -$1.3 million in Q1 2026.
- Quarterly Free Cash Flow fell 163.97% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.8 million (changed N/A YoY) and the FY2025 annual result came in at -$1.9 million, up 27.75% from the prior year.
- Free Cash Flow slipped to -$1.3 million in Q1 2026, from -$488293.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$488293.0 in Q1 2025 to a low of -$1.3 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 279.60 Mn |
| 10 | 20 | 6.00 Mn | 1.45 Mn | 304,727.00 | -605,460.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29 Mn |
| Mar 31, 2026 | -1.29 Mn |
| Mar 31, 2025 | -488,293.00 |
| Mar 31, 2025 | -488,293.00 |